Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 1
1990 1
1992 1
1993 2
1994 1
1995 2
1997 3
1998 1
1999 3
2002 3
2003 1
2004 2
2005 5
2006 9
2007 14
2008 10
2009 13
2010 12
2011 12
2012 23
2013 22
2014 13
2015 17
2016 31
2017 34
2018 27
2019 25
2020 14
2021 14
2022 20
2023 17
2024 8
2025 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

317 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study.
Bril V, Drużdż A, Grosskreutz J, Habib AA, Mantegazza R, Sacconi S, Utsugisawa K, Vissing J, Vu T, Boehnlein M, Bozorg A, Gayfieva M, Greve B, Woltering F, Kaminski HJ; MG0003 study team. Bril V, et al. Lancet Neurol. 2023 May;22(5):383-394. doi: 10.1016/S1474-4422(23)00077-7. Lancet Neurol. 2023. PMID: 37059507 Clinical Trial.
Reprogramming of gastrointestinal cancer cells.
Dewi D, Ishii H, Haraguchi N, Nishikawa S, Kano Y, Fukusumi T, Ohta K, Miyazaki S, Ozaki M, Sakai D, Satoh T, Nagano H, Doki Y, Mori M. Dewi D, et al. Among authors: haraguchi n. Cancer Sci. 2012 Mar;103(3):393-9. doi: 10.1111/j.1349-7006.2011.02184.x. Epub 2012 Jan 17. Cancer Sci. 2012. PMID: 22151786 Free PMC article. Review.
Anatomical Pathology of Subtle Lisfranc Injury.
Haraguchi N, Ota K, Ozeki T, Nishizaka S. Haraguchi N, et al. Sci Rep. 2019 Oct 16;9(1):14831. doi: 10.1038/s41598-019-51358-8. Sci Rep. 2019. PMID: 31619712 Free PMC article.
Targeting cancer stem cells in refractory cancer.
Miyoshi N, Haraguchi N, Mizushima T, Ishii H, Yamamoto H, Mori M. Miyoshi N, et al. Among authors: haraguchi n. Regen Ther. 2021 Feb 5;17:13-19. doi: 10.1016/j.reth.2021.01.002. eCollection 2021 Jun. Regen Ther. 2021. PMID: 33598510 Free PMC article. Review.
[Cancer stem cell].
Sakashita H, Ieta K, Haraguchi N, Inoue Y, Yoshizawa Y, Mori M. Sakashita H, et al. Among authors: haraguchi n. Gan To Kagaku Ryoho. 2007 Nov;34(11):1721-9. Gan To Kagaku Ryoho. 2007. PMID: 18030004 Review. Japanese.
[Esophageal cancer].
Satoh T, Kudo T, Sakai D, Haraguchi N, Ishii H, Doki Y, Mori M. Satoh T, et al. Among authors: haraguchi n. Nihon Rinsho. 2012 Nov;70 Suppl 8:434-7. Nihon Rinsho. 2012. PMID: 23513879 Japanese. No abstract available.
microRNA-based cancer cell reprogramming technology.
Nishikawa S, Ishii H, Haraguchi N, Kano Y, Fukusumi T, Ohta K, Ozaki M, Dewi DL, Sakai D, Satoh T, Nagano H, Doki Y, Mori M. Nishikawa S, et al. Among authors: haraguchi n. Exp Ther Med. 2012 Jul;4(1):8-14. doi: 10.3892/etm.2012.558. Epub 2012 Apr 23. Exp Ther Med. 2012. PMID: 23060915 Free PMC article.
Cancer stem cells and chemoradiation resistance.
Ishii H, Iwatsuki M, Ieta K, Ohta D, Haraguchi N, Mimori K, Mori M. Ishii H, et al. Among authors: haraguchi n. Cancer Sci. 2008 Oct;99(10):1871-7. doi: 10.1111/j.1349-7006.2008.00914.x. Cancer Sci. 2008. PMID: 19016744 Free PMC article. Review.
317 results